scPharmaceuticals announced that on October 2, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate of 52,500 shares of its common stock to 14 new employees comprised of sales representatives. These stock options are subject to the terms of the scPharmaceuticals Inc. 2023 Employment Inducement Award Plan. The Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to their entering into employment with scPharmaceuticals pursuant to Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was adopted by scPharmaceuticals’ board of directors in February 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SCPH:
- scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Craig-Hallum bullish on scPharmaceuticals, initiates with a Buy
- scPharmaceuticals initiated with a Buy at Craig-Hallum
- scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
- scPharmaceuticals reports Q2 EPS (35c), consensus (37c)